{"id":10101,"date":"2026-01-29T23:02:28","date_gmt":"2026-01-29T23:02:28","guid":{"rendered":"https:\/\/mailitics.com\/index.php\/2026\/01\/29\/readout-loud-podcast-huntingtons-patients-uniqure-gene-therapy\/"},"modified":"2026-01-29T23:02:28","modified_gmt":"2026-01-29T23:02:28","slug":"readout-loud-podcast-huntingtons-patients-uniqure-gene-therapy","status":"publish","type":"post","link":"https:\/\/mailitics.com\/index.php\/2026\/01\/29\/readout-loud-podcast-huntingtons-patients-uniqure-gene-therapy\/","title":{"rendered":"The high stakes for Huntington\u2019s patients"},"content":{"rendered":"<p>    The high stakes for Huntington\u2019s patients<br \/>\n \t<BR><br \/>\n<BR><\/BR><br \/>\n    <!-- no image --><br \/>\n \t<BR><br \/>\n<BR><\/BR><\/p>\n<div>\n<p>Biotech company UniQure is set to meet with the Food and Drug Administration to discuss the path forward for its gene therapy for Huntington\u2019s disease, and the outcome could be potentially devastating for patients. <\/p>\n<p>That\u2019s what patient advocate Lauren Holder says on the latest episode of \u201cThe Readout LOUD,\u201d STAT\u2019s weekly biotech podcast.\u00a0Holder joins the podcast for an in-depth discussion of how the regulator\u2019s changing perspective on UniQure\u2019s trial affects patients, and patients\u2019 attempts to petition the agency to reverse course.<\/p>\n<p><a href=\"https:\/\/www.statnews.com\/2026\/01\/29\/readout-loud-podcast-huntingtons-patients-uniqure-gene-therapy\/?utm_campaign=rss\">Read the rest\u2026<\/a><\/p>\n<\/div>\n<p> \t<BR><br \/>\n <BR><\/BR><br \/>\n    Allison DeAngelis, Adam Feuerstein, and Elaine Chen<br \/>\n \t<BR><br \/>\n<BR><\/BR><br \/>\n<a href=\"https:\/\/www.statnews.com\/2026\/01\/29\/readout-loud-podcast-huntingtons-patients-uniqure-gene-therapy\/?utm_campaign=rss\">Go to statnews<\/a><br \/>\n \t<BR><br \/>\n <BR><\/BR><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The high stakes for Huntington\u2019s patients Biotech company UniQure is set to meet with the Food and Drug Administration to discuss the path forward for its gene therapy for Huntington\u2019s disease, and the outcome could be potentially devastating for patients. That\u2019s what patient advocate Lauren Holder says on the latest episode of \u201cThe Readout LOUD,\u201d [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2154,2280,2209,2659,2215,2265],"tags":[2150],"class_list":["post-10101","post","type-post","status-publish","format-standard","hentry","category-biotechnology","category-clinical-trials","category-drug-prices","category-gene-therapy","category-medicare","category-the-readout-loud","tag-statnews"],"_links":{"self":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts\/10101"}],"collection":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/comments?post=10101"}],"version-history":[{"count":0,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts\/10101\/revisions"}],"wp:attachment":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/media?parent=10101"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/categories?post=10101"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/tags?post=10101"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}